Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Kedudukan dalam Saham #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Harga Saham
$4.84
Modal Pasaran
$633.18M
Perubahan (1 hari)
3.20%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Exscientia plc (EXAI)

Kategori

Healthcare
Pendapatan untuk Exscientia plc (EXAI)
Pendapatan pada Sep 2024 TTM: $-207.65M
Menurut laporan kewangan terkini Exscientia plc, pendapatan semasa syarikat ialah $-207.65M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $-167.36M, penurunan berbanding pendapatan pada tahun 2021 yang berjumlah $-56.36M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Exscientia plc dari 2019 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-207.65M 0.64%
2023 $-206.34M 23.29%
2022 $-167.36M 196.95%
2021 $-56.36M 24.08%
2020 $-45.42M 224.78%
2019 $-13.99M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$20.46B -9,951.57%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -2,336.03%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -2,618.95%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -1,129.45%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -877.39%
AU